RxDoctor Payments Data
★ My doctorsLook up a doctor →

Lisa Umholtz

Plano, TXNPI 1376651570

Payments from drug & device makers

$1,067in general payments, 2019–2025

Across 64 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$299
  • Pfizer$105
  • Avion Pharmaceuticals$57
  • Amgen$51
  • Millicent US Inc$49
  • Myovant Sciences Inc.$48
  • plus $457 from 16 others

What the payments were for

  • Food & beverage$1,067100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)18$299
Pfizer6$105
Avion Pharmaceuticals4$57
Amgen3$51
Millicent US Inc2$49
Myovant Sciences Inc.3$48
Therapeuticsmd, Inc.3$46
Virtus Pharmaceuticals LLC3$45
Hologic Sales And Service, LLC2$45
Scynexis, Inc.2$43
Vertical Pharmaceuticals, LLC2$43
Mylan Pharmaceuticals Inc.2$40
Duchesnay USA Incorporated3$37
Agile Therapeutics, Inc.2$30
Organon2$24
Evofem Biosciences, Inc.1$17
Sumitomo Pharma America, Inc.1$16
Bausch Health US, LLC1$16
Ascend Therapeutics US, LLC1$15
Astellas Pharma US Inc1$15
Novo Nordisk1$14
BD1$11

Where these figures come from

Is this you, or does something look wrong? →